Work package 1

Project management, communication and dissemination

All project activities are coordinated by work package 1 (WP1), which is supported by two Advisory Boards. This WP1 is jointly led by the Project Leader (Janssen Pharmaceutica NV) and the Project Coordinator (University Hospital of Bonn). Project management, communication and dissemination of scientific work as well as all legal and financial aspects are conducted within this work package. A Project Executive (PE) consisting of the Project Coordinator, the Project Leader and one representative each from King's College London and Sanofi supported by a project management expert (ARTTIC) as well as an administration office of Janssen Pharmaceutica NV will ensure the proper functioning of the project in order to achieve the objectives, complete the milestones and deliverables, and meet all contractual commitments towards the IMI JU. Coordination of the scientific activities and work progress are supported by the individual work package leaders.

 

 

 

 

 

 

 

Overall structure of PHAGO

Overall structure of PHAGO

Home
Menu
Top
 

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115976. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA companies.

Social Media

PHAGO by Twitter PHAGO by LinkedIn

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115976. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA companies.